The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Micafungin: A New Echinocandin
Abstract
Micafungin, a potent inhibitor of 1,3-beta-D-glucan synthase, has become the second available agent in the echinocandins class that is approved for use in clinical practice. This agent shares with caspofungin an identical spectrum of in vitro activity against Candida albicans, non-albicans species of Candida, and Aspergillus species, as well as several but not all pathogenic molds. If anything, its in vitro activity appears to be superior to that of caspofungin, although the clinical relevance of this observation is unclear. The clinical role of micafungin appears to be similar to that of caspofungin, although clinical data are still lacking at this stage, with initial approval only for treatment of esophageal candidiasis and prophylaxis in subjects with neutropenia. Pharmacokinetic and pharmacodynamic studies and reports of adverse effects and safety have reported similar but not identical results to those of other agents in the echinocandin class. Factors such as acquisition costs and the potential for resistance development may be more relevant to its widespread use than in vitro and in vivo data comparisons with caspofungin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 919
Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 764
van Burik, J.-A. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J. W., Satoi, Y., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/422312 · Cited by 744
Maertens, J., Raad, I., Petrikkos, G., Boogaerts, M., Selleslag, D., Petersen, F. B., Sable, C. A., Kartsonis, N. A., Ngai, A., Taylor, A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/423381 · Cited by 658
Marr, K. A., Seidel, K., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 511
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
Ostrosky-Zeichner, L., Rex, J. H., Pappas, P. G., Hamill, R. J., Larsen, R. A., Horowitz, H. W., Powderly, W. G., Hyslop, N., Kauffman, C. A., Cleary, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3149-3154.2003 · Cited by 498
Tawara, S., Ikeda, F., Maki, K., Morishita, Y., Otomo, K., Teratani, N., Goto, T., Tomishima, M., Ohki, H., Yamada, A., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.57-62.2000 · Cited by 311
Villanueva, A., Gotuzzo, E., Arathoon, E. G., Noriega, L. M., Kartsonis, N. A., Lupinacci, R. J., Smietana, J. M., DiNubile, M. J., & Sable, C. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01191-9 · Cited by 292
Single- and Multiple-Dose Pharmacokinetics of Caspofungin in Healthy Men
Stone, J. A., Holland, S. D., Wickersham, P. J., Sterrett, A., Schwartz, M., Bonfiglio, C., Hesney, M., Winchell, G. A., Deutsch, P. J., Greenberg, H., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.739-745.2002 · Cited by 246
Seibel, N. L., Schwartz, C., Arrieta, A., Flynn, P., Shad, A., Albano, E., Keirns, J., Lau, W. M., Facklam, D. P., Buell, D. N., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3317-3324.2005 · Cited by 243
Krause, D. S., Simjee, A. E., van Rensburg, C., Viljoen, J., Walsh, T. J., Goldstein, B. P., Wible, M., & Henkel, T. (2004) · Clinical Infectious Diseases · doi:10.1086/423378 · Cited by 242
Moudgal, V., Little, T., Boikov, D., & Vazquez, J. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.767-769.2005 · Cited by 242
Petraitis, V., Petraitiene, R., Sarafandi, A. A., Kelaher, A. M., Lyman, C. A., Casler, H. E., Sein, T., Groll, A. H., Bacher, J., Avila, N. A., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/375420 · Cited by 233
Lipopeptide inhibitors of fungal glucan synthase
Kurtz, M. B., & Douglas, C. M. (1997) · Medical Mycology · doi:10.1080/02681219780000961 · Cited by 216
de Wet, N., Cuentas, A. L., Suleiman, J., Baraldi, E., Krantz, E. F., Della Negra, M., & Diekmann-Berndt, H. (2004) · Clinical Infectious Diseases · doi:10.1086/423377 · Cited by 204
Caspofungin Therapy of Neonates With Invasive Candidiasis
Odio, C. M., Araya, R., Pinto, L. E., Castro, C. E., Vasquez, S., Alfaro, B., Sàenz, A., Herrera, M. L., & Walsh, T. J. (2004) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000145408.51526.0a · Cited by 202
Petraitis, V., Petraitiene, R., Groll, A. H., Roussillon, K., Hemmings, M., Lyman, C. A., Sein, T., Bacher, J., Bekersky, I., & Walsh, T. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1857-1869.2002 · Cited by 182
Kohno, S., Masaoka, T., Yamaguchi, H., Mori, T., Urabe, A., Ito, A., Niki, Y., & IKEMOTO, H. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410020406 · Cited by 154
Ikeda, F., Wakai, Y., Matsumoto, S., Maki, K., Watabe, E., Tawara, S., Goto, T., Watanabe, Y., Matsumoto, F., & Kuwahara, S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.614-618.2000 · Cited by 147
Wet, N. T. E. D., Bester, A. J., Viljoen, J., Filho, F. A. B. D. O., Suleiman, J. M. A. H., Ticona, E., Llanos, E. A., Fisco, C., Lau, W. M., & Buell, D. N. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02427.x · Cited by 145
From natural products to clinically useful antifungals
Barrett, D. G. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00085-6 · Cited by 126
Chiou, C. C., Mavrogiorgos, N., Tillem, E., Hector, R., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3310-3321.2001 · Cited by 117
Marr, K. A., Hachem, R. Y., Papanicolaou, G. A., Somani, J., Arduino, J. M., Lipka, C. J., Ngai, A., Kartsonis, N. A., Chodakewitz, J., & Sable, C. (2004) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2004.00065.x · Cited by 117
Concomitant Cyclosporine and Micafungin Pharmacokinetics in Healthy Volunteers
Hébert, M. F., Townsend, R. W., Austin, S. M., Balan, G., Blough, D. K., Buell, D. N., Keirns, J. J., & Bekersky, I. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005278601 · Cited by 107
FK463, a Novel Water-soluble Echinocandin Lipopeptide. Synthesis and Antifungal Activity.
Tomishima, M., Ohki, H., Yamada, A., Takasugi, H., Maki, K., Tawara, S., & Tanaka, H. (1999) · The Journal of Antibiotics · doi:10.7164/antibiotics.52.674 · Cited by 107
In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide
Mikamo, H., Sato, Y., & Tamaya, T. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.485 · Cited by 100
Concomitant Tacrolimus and Micafungin Pharmacokinetics in Healthy Volunteers
Hébert, M. F., Blough, D. K., Townsend, R. W., Allison, M. J., Buell, D. N., Keirns, J. J., & Bekersky, I. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005279274 · Cited by 93
Efficacy of Micafungin Alone or in Combination against Systemic Murine Aspergillosis
Capilla, J., Clemons, K. V., & Stevens, D. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1452-1455.2003 · Cited by 91
Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Pulmonary Aspergillosis
Matsumoto, S., Wakai, Y., Nakai, T., Hatano, K., Ushitani, T., Ikeda, F., Tawara, S., Goto, T., Matsumoto, F., & Kuwahara, S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.619-621.2000 · Cited by 89
Sanz-Rodrı́guez, C., López‐Duarte, M., Jurado, M., Lopez, J., Arranz, R., Cisneros, J. M., Martino, M. L., García-Sánchez, P., Morales, P., Olivé, T., et al. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704516 · Cited by 84
Uchida, K., NISHIYAMA, Y., Yokota, N., & YAMAGUCHI, H. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.1175 · Cited by 79
Antifungal Mechanism of FK463 against Candida albicans and Aspergillus fumigatus.
HATANO, K., MORISHITA, Y., Nakai, T., & Ikeda, F. (2002) · The Journal of Antibiotics · doi:10.7164/antibiotics.55.219 · Cited by 77
Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent
Pettengell, K., Mynhardt, J., Kluyts, T., Lau, W. M., Facklam, D., Buell, D. N., & the FK463 South African Study Group (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02083.x · Cited by 76
Maesaki, S., Hossain, M. A., Miyazaki, Y., Tomono, K., Tashiro, T., & Kohno, S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1728-1730.2000 · Cited by 75
Laverdière, M., Hoban, D., Restieri, C., & Habel, F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf074 · Cited by 73
Warn, P. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg185 · Cited by 68
Nakai, T., Uno, J., Otomo, K., Ikeda, F., Tawara, S., Goto, T., Nishimura, K., & Miyaji, M. (2002) · Chemotherapy · doi:10.1159/000057666 · Cited by 67
Nishiyama, Y. (2002) · Journal of Electron Microscopy · doi:10.1093/jmicro/51.4.247 · Cited by 64
Chandrasekar, P. H., Cutright, J. L., & Manavathu, E. K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00958.x · Cited by 60
Self-citationCombination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin
Graybill, J. R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg425 · Cited by 55
Carver, P. L. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d301 · Cited by 51
Ito, M., Nozu, R., Kuramochi, T., Eguchi, N., Suzuki, S., Hioki, K., Itoh, T., & Ikeda, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2259-2262.2000 · Cited by 50
Micafungin: pharmacology, experimental therapeutics and clinical applications
Groll, A. H., Stergiopoulou, T., Roilides, E., & Walsh, T. J. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.4.489 · Cited by 39
Warn, P. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf247 · Cited by 38
Fromtling, R. A. (2002) · Drugs of today · doi:10.1358/dot.2002.38.4.820091 · Cited by 30
Matsumoto, Y., Doğru, M., Goto, E., Fujishima, H., & Tsubota, K. (2005) · Cornea · doi:10.1097/01.ico.0000154390.28254.54 · Cited by 27
Ota, S., Tanaka, J., Kahata, K., Toubai, T., Kondo, K., Mori, A., Toyoshima, N., Musashi, M., Asaka, M., & Imamura, M. (2004) · International Journal of Hematology · doi:10.1532/ijh97.03163 · Cited by 23
Effect of Micafungin (FK463) on Candida albicans Adherence to Epithelial Cells
Zepelin, M. B., Zaschke, K., Groß, U., Monod, M., & Müller, F. C. (2002) · Chemotherapy · doi:10.1159/000064921 · Cited by 20
Micafungin Enhances Neutrophil Fungicidal Functions against Candida Pseudohyphae
Gil‐Lamaignere, C., Salvenmoser, S., Hess, R., & Müller, F. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2730-2732.2004 · Cited by 17
Successful Treatment of Invasive Aspergillosis in Two Patients With Acute Myelogenous Leukemia
Singer, M. S., Seibel, N. L., Vézina, G., Choi, S. S., & Dinndorf, P. A. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200303000-00014 · Cited by 15
Ninomiya, M., Mikamo, H., Tanaka, K. Y., Watanabe, K., & Tamaya, T. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki024 · Cited by 14
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Self-citationEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793
Self-citationEchinocandin Antifungal Drugs in Fungal Infections: A Comparison
Chen, S. C.-A., Slavin, M. A., & Sorrell, T. C. (2011) · Drugs · doi:10.2165/11585270-000000000-00000 · Cited by 371
Metadata
- Authors
- Chandrasekar, P. H., & Sobel, J. D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-15
- Volume
- 42
- Issue
- 8
- Pages
- 1171-1178
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2147069968
- Cited by
- 256
- References
- 53
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.